212
Participants
Start Date
December 4, 2024
Primary Completion Date
October 31, 2029
Study Completion Date
October 31, 2029
Non-Interventional Study
Non-Interventional Study
RECRUITING
Ospedale Regionale di Lugano, Civico, Lugano
NOT_YET_RECRUITING
Memorial Sloan Kettering Cancer Center, New York
NOT_YET_RECRUITING
Ospedale Michele e Pietro Ferrero, Verduno
NOT_YET_RECRUITING
Fondazione IRCCS Istituto Nazionale Tumori, Milan
NOT_YET_RECRUITING
European Institute of Oncology, Milan
NOT_YET_RECRUITING
IRCCS Fondazione San Gerardo dei Tintori, Monza
RECRUITING
Hospital Universitario La Paz, Madrid
NOT_YET_RECRUITING
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse
NOT_YET_RECRUITING
University of Udine, Udine
RECRUITING
Hospital Materno of Las Palmas, Las Palmas
NOT_YET_RECRUITING
University Hospital Essen, Essen
RECRUITING
Mayo Clinic in Rochester, Rochester
NOT_YET_RECRUITING
Houston Methodist Hospital, Houston
NOT_YET_RECRUITING
Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples
RECRUITING
Medical University of Vienna, Vienna
NOT_YET_RECRUITING
AC Camargo Cancer Center, São Paulo
NOT_YET_RECRUITING
Meir Medical Center, Faculty of Medicine - Tel-Aviv University, Kefar Sava
NOT_YET_RECRUITING
Sunnybrook Health Sciences, University of Toronto, Toronto
NOT_YET_RECRUITING
Hopital Maisonneuve Rosemont, Montreal
NOT_YET_RECRUITING
Policlinico Universitario Fondazione Agostino Gemelli, Roma
Lead Sponsor
Mayo Clinic
OTHER